PortfoliosLab logo

Avenue Therapeutics, Inc. (ATXI)

Equity · Currency in USD · Last updated Nov 30, 2022

Company Info

ISINUS05360L2051
CUSIP05360L205
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.31
Year Range$1.31 - $19.80
EMA (50)$2.77
EMA (200)$6.39
Average Volume$5.54M
Market Capitalization$6.26M

ATXIShare Price Chart


Loading data...

ATXIPerformance

The chart shows the growth of $10,000 invested in Avenue Therapeutics, Inc. in Jun 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $106 for a total return of roughly -98.94%. All prices are adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%JulyAugustSeptemberOctoberNovember
-67.68%
-5.25%
ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

ATXICompare to other instruments

Search for stocks, ETFs, and funds to compare with ATXI

ATXIReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-48.02%1.45%
6M-66.44%-4.82%
YTD-90.38%-16.96%
1Y-92.13%-13.86%
5Y-53.01%8.56%
10Y-56.79%9.50%

ATXIMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-19.47%-53.51%41.66%-23.22%-24.26%-3.82%-4.79%-6.08%179.07%-76.29%-45.19%
2021-0.50%-20.61%29.15%-15.65%-3.12%-49.40%-28.69%1.12%-17.68%6.04%-10.76%-35.60%
20201.98%-9.30%0.68%6.26%20.74%-6.10%-5.94%9.87%-2.70%-71.01%7.96%75.52%
201912.78%-8.87%-14.41%3.79%5.48%21.15%-5.56%5.88%-5.40%-3.86%2.97%62.71%
20184.14%35.54%-11.74%-15.96%6.86%-11.60%10.34%-9.11%-21.45%25.18%47.59%3.65%
2017-3.64%-15.97%-12.35%-5.55%-3.80%-21.80%-12.98%

ATXISharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Avenue Therapeutics, Inc. Sharpe ratio is -0.36. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.00JulyAugustSeptemberOctoberNovember
-0.39
-0.63
ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

ATXIDividend History


Avenue Therapeutics, Inc. doesn't pay dividends

ATXIDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovember
-99.28%
-17.49%
ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)

ATXIWorst Drawdowns

The table below shows the maximum drawdowns of the Avenue Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Avenue Therapeutics, Inc. is 99.28%, recorded on Nov 29, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.28%Sep 15, 2020557Nov 29, 2022
-74.55%Jun 28, 2017325Oct 10, 2018304Dec 26, 2019629
-43.11%Feb 11, 202026Mar 18, 202050May 29, 202076
-18.31%Jun 1, 202030Jul 13, 202026Aug 18, 202056
-11.46%Jan 2, 202010Jan 15, 20208Jan 28, 202018
-7.42%Aug 21, 20205Aug 27, 202011Sep 14, 202016
-4.24%Jan 29, 20202Jan 30, 20202Feb 3, 20204
-2.29%Feb 5, 20201Feb 5, 20201Feb 6, 20202

ATXIVolatility Chart

Current Avenue Therapeutics, Inc. volatility is 83.39%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%200.00%400.00%600.00%800.00%JulyAugustSeptemberOctoberNovember
83.39%
13.39%
ATXI (Avenue Therapeutics, Inc.)
Benchmark (^GSPC)